Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Traditional and Herbal Drugs ; (24): 3074-3081, 2018.
Article in Chinese | WPRIM | ID: wpr-851871

ABSTRACT

Objective: To investigate effect of Schisandrae Chinensis Fructus powder in D-galactose-induced aging model mice. Methods: Seventy-two Kunming mice were randomly divided into normal group, model group, Naokangling group (0.810 g/kg), and low-, mid-, and high-dose (3.00, 1.50, 0.75 g/kg) Schisandrae Chinensis Fructus powder groups. Aging mice model was established by sc injection of D-galactose 1.25 g/kg at neck back once daily for 40 d. Naokangling and Schisandrae Chinensis Fructus powder were orally administrated on day 11 for 30 d. Then the learning and memory ability was assessed by step-through test on day 39. Two hours after the last administration, the contents of malonaldehyde (MDA) in brain homogenate, liver homogenate, and plasma and the activity of superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) in whole blood were detected; The morphological changes of brain, liver, thymus, and spleen in each group of mice were observed by light microscope. Results: Compared with model groups, the Schisandrae Chinensis Fructus powder groups can improve the incubation period and reduce the number of times of light and dark shuttle of model mice; The Schisandrae Chinensis Fructus powder groups can reduce the level of MDA in plasma, brain, and liver homogenate, and increase the levels of CAT, SOD, and GSH in the whole blood in different degrees; It also can elevate the index of spleen, thymus, and brain, and decrease the indexes of liver in different degrees. Conclusion: Schisandrae Chinensis Fructus powder can significantly improve the biochemical indexes and pathological status of aging model mice.

2.
Chinese Journal of Infectious Diseases ; (12): 212-216, 2009.
Article in Chinese | WPRIM | ID: wpr-395042

ABSTRACT

Objective To establish and improve the acute hepatic failure model in pigs induced with D-galactosamine (D-gal),and explore the feasibility of evaluating preclinical artificial liver devices.Methods Nineteen Duroc breeding pigs were divided into 4 groups.Fifteen unanesthetic Duroc breeding pigs out of 19 (5 of each group) received intravenously administration of D-gal at a dose of 1.0,1.25 and 1.5 g/kg body weight,respectively.The remaining 4 pigs which received the same volume of 5% dextrose in water served as controls. Clinical data and survival time of pigs were recorded.Blood samples were collected for dynamic testing of plasma ammonia,prothrombin time,liver and renal functions,blood glucose and L-lactate;liver tissues were sampled for pathological examination.The differences between groups were compared using t test and F test.The survival time of pigs was compared by Kaplan-Meier survival analysis and Log Rank test.Results Twelve hours after administration of D-gal,all pigs presented as acute hepatic failure characterized by progressive increases of levels of plasma ammonia,aspartate aminotransferase (AST),total bilirubin (TBil) and L-lactate,the level of blood glucose marked decreased and prothrombin time prolonged (F= 32.33,F=27.817,F=50.097,F=88.382,F=8.211,F=21.227;all P<0.01);especially in the pigs which received D-gal at a dose of 1.5 g/kg.Except 2 pigs survived for 168 h,the other 3 pigs which received D-gal at a dose of 1.0 g/kg died within 68-84 h,while all pigs which received D-gal at a dose of 1.25 and 1.5 g/kg died within 33-89 h and 23-47 h,respectively.All pigs presented coma before death and liver histopathological examination indicated massive hepatic necrosis with severe hemorrhage.Conclusions D-gal induced acute hepatic failure model in unanesthetic Duroc breeding pig appears potential reversibility and high reproducibility,which has proper therapeutic window.Thus,this model could be applied to evaluate the therapeutic effects and safety of artificial liver devices.

SELECTION OF CITATIONS
SEARCH DETAIL